药物对比
Tirzepatide vs Tolbutamide
比较 Tirzepatide 与 Tolbutamide 治疗 2 型糖尿病。双重 GIP/GLP-1 激动剂（注射剂，A1C/体重降幅大）vs 口服第一代磺脲类（低血糖风险）。
此页面暂无可用的对比维度。
临床背景
Patients with type 2 diabetes weighing a modern weekly injectable dual-incretin therapy against an older oral first-generation sulfonylurea.
结论
Tirzepatide usually delivers superior glycemic and weight benefits, while Tolbutamide offers a low-cost oral alternative with distinct hypoglycemia risks.
全部药物对比